Gyre Therapeutics Inc. (GYRE) — Free Cash Flow Generation Index
Gyre Therapeutics Inc. (GYRE) has a Free Cash Flow Generation Index of 0.85x as of September 2025. Free cash flow of $3.99 Million represents 1% of operating cash flow ($4.68 Million). See GYRE current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Gyre Therapeutics Inc. Free Cash Flow Generation Index (2007–2023)
Historical FCF Generation Index trend for Gyre Therapeutics Inc. across 4 annual periods. Explore Gyre Therapeutics Inc. (GYRE) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Gyre Therapeutics Inc. (2007–2023)
Year-by-year Free Cash Flow Generation Index for Gyre Therapeutics Inc.. For the full company profile including market capitalisation, see market value of Gyre Therapeutics Inc..
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.67x | $17.31 Million | $25.89 Million | $8.59 Million | ▲ +25.7% |
| 2022 | 0.53x | $5.68 Million | $10.68 Million | $5.00 Million | ▼ -45.5% |
| 2010 | 0.98x | $134.99 Million | $138.30 Million | $3.31 Million | ▲ +21.9% |
| 2007 | 0.80x | $19.89 Million | $24.84 Million | $4.94 Million | — |